Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows (Unaudited)

v3.23.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Operating activities    
Net loss $ (9,955) $ (22,051)
Adjustments to reconcile net loss used in operating activities:    
Depreciation and amortization 33 67
Stock-based compensation 855 5,312
Accretion of debt discount 350 350
Deferred taxes 8 9
Change in fair value of derivative liability 180 0
Changes in assets and liabilities:    
Accounts receivable, net 0 123
Other receivables 1,062 2,294
Inventory, net 1 13
Prepaid expenses and other assets (337) (310)
Accounts payable 2,683 388
Deferred revenue 22 0
Accrued expenses and other liabilities (4,941) (2,287)
Lease liability, net (13) 25
Net cash used in operating activities (10,052) (16,067)
Investing activities    
Leasehold improvements (158) 0
Disposal of property and equipment 25 0
Net cash used in investing activities (133) 0
Financing activities    
Proceeds from issuance of common stock and warrants in underwritten public offering, net 13,748 0
Net cash provided by financing activities 13,748 0
Increase (decrease) in cash, cash equivalents and restricted cash 3,563 (16,067)
Cash, cash equivalents, and restricted cash at beginning of period 13,318 54,863
Cash, cash equivalents, and restricted cash at end of period 16,881 38,796
Supplemental disclosures of cash flow information    
Cash paid for interest 704 831
Cash and cash equivalents 16,687 38,469
Restricted cash, current 63 100
Restricted cash, non-current 131 227
Total cash, cash equivalents and restricted cash $ 16,881 $ 38,796